You are here

  • Home
  • Archive
  • Volume 71, Issue 11
  • Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gottenberg JE, Ravaud P, Cantagrel A, et al
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
Annals of the Rheumatic Diseases 2012;71:1815-1819.